Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid Thomson, Sue S. Yom, Mererid Evans et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 211
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision makingNicolaus Andratschke, Carsten Nieder, Jonas Willmann et al.|The Lancet Oncology|2022Cited by 192
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Panagiotis Balermpas|International Journal of Cancer|2017Cited by 98
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platformJonas Willmann, Nicolaus Andratschke, Ane Appelt et al.|Radiotherapy and Oncology|2023Cited by 72
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials databaseJonas Willmann, Nicolaus Andratschke, Panagiotis Balermpas et al.|Radiotherapy and Oncology|2024Cited by 12